2 news items
FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
GH
23 May 24
Cancer Roundtable. 80% in Every Community
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
GH
21 May 24
profiling with IVDR-certified liquid biopsy will help the cancer care community establish more clinically relevant biomarkers to improve diagnosis
- Prev
- 1
- Next